Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?

被引：0
|
作者：
Leon M. T. Dicks
Shelly M. Deane
Matthew J. Grobbelaar
机构：
[1] Stellenbosch University,Department of Microbiology
来源：
Probiotics and Antimicrobial Proteins | 2022年 / 14卷
关键词：
Ivermectin; Gut microbiota; SARS-CoV-2; COVID-19;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The microfilaricidal anthelmintic drug ivermectin (IVM) has been used since 1988 for treatment of parasitic infections in animals and humans. The discovery of IVM’s ability to inactivate the eukaryotic importin α/β1 heterodimer (IMPα/β1), used by some viruses to enter the nucleus of susceptible hosts, led to the suggestion of using the drug to combat SARS-CoV-2 infection. Since IVM has antibacterial properties, prolonged use may affect commensal gut microbiota. In this review, we investigate the antimicrobial properties of IVM, possible mode of activity, and the concern that treatment of individuals diagnosed with COVID-19 may lead to dysbiosis.
引用
收藏
页码：217 / 223
页数：6
相关论文
共 24 条
  • [1] Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?
    Dicks, Leon M. T.
    Deane, Shelly M.
    Grobbelaar, Matthew J.
    [J]. PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2022, 14 (02) : 217 - 223
  • [2] Dysbiosis of gut microbiota in patients with severe COVID-19
    Shimizu, Kentaro
    Hirata, Haruhiko
    Tokuhira, Natsuko
    Motooka, Daisuke
    Nakamura, Shota
    Ueda, Akiko
    Tachino, Jotaro
    Koide, Moe
    Uchiyama, Akinori
    Ogura, Hiroshi
    Oda, Jun
    [J]. ACUTE MEDICINE & SURGERY, 2024, 11 (01):
  • [3] Is Gut Microbiota Dysbiosis a Predictor of Increased Susceptibility to Poor Outcome of COVID-19 Patients? An Update
    Ferreira, Carolina
    Viana, Sofia D.
    Reis, Flavio
    [J]. MICROORGANISMS, 2021, 9 (01) : 1 - 12
  • [4] Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
    Ancona, Giuseppe
    Alagna, Laura
    Alteri, Claudia
    Palomba, Emanuele
    Tonizzo, Anna
    Pastena, Andrea
    Muscatello, Antonio
    Gori, Andrea
    Bandera, Alessandra
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] Physician Response to COVID-19-Driven Telehealth Flexibility for Opioid Use Disorder
    Beetham, Tamara
    Fiellin, David A.
    Busch, Susan H.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (09): : 456 - 463
  • [6] Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy
    Martin Gimenez, Virna Margarita
    Modrego, Javier
    Gomez-Garre, Dulcenombre
    Manucha, Walter
    de las Heras, Natalia
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [7] COVID-19 Pandemic and Dysbiosis: Can the Ivermectin Hysteria Lead to an Increase of Autoimmune Neuroinflammatory Diseases?
    Peron, J. P. S.
    Nakaya, H., I
    Schlindwein, M. A. M.
    Goncalves, M. V. M.
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 2020, 40 (06) : 537 - 542
  • [8] Experiences from COVID-19-driven use of telephone consultations in a cardiology clinic-The CoviTel study
    Hundeboll, Astrid Brink
    Rosenstrom, Stine
    Jensen, Magnus Thorsten
    Dixen, Ulrik
    [J]. PLOS ONE, 2022, 17 (10):
  • [9] Gut Microbiota Dysbiosis Correlates With Long COVID-19 at One-Year After Discharge
    Zhang, Dongmei
    Zhou, Yaya
    Ma, Yanling
    Chen, Ping
    Tang, Jian
    Yang, Bohan
    Li, Hui
    Liang, Mengyuan
    Xue, Yue
    Liu, Yao
    Zhang, Jianchu
    Wang, Xiaorong
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (15)
  • [10] Gut microbiota dysbiosis is associated with altered tryptophan metabolism and dysregulated inflammatory response in COVID-19
    Essex, Morgan
    Pascual-Leone, Belen Millet
    Loeber, Ulrike
    Kuhring, Mathias
    Zhang, Bowen
    Bruening, Ulrike
    Fritsche-Guenther, Raphaela
    Krzanowski, Marta
    Vernengo, Facundo Fiocca
    Brumhard, Sophia
    Roewekamp, Ivo
    Bielecka, Agata Anna
    Lesker, Till Robin
    Wyler, Emanuel
    Landthaler, Markus
    Mantei, Andrej
    Meisel, Christian
    Caesar, Sandra
    Thibeault, Charlotte
    Corman, Victor M.
    Marko, Lajos
    Suttorp, Norbert
    Strowig, Till
    Kurth, Florian
    Sander, Leif E.
    Li, Yang
    Kirwan, Jennifer A.
    Forslund, Sofia K.
    Opitz, Bastian
    [J]. NPJ BIOFILMS AND MICROBIOMES, 2024, 10 (01)
123